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ypoplastic left heart syndrome (HLHS) is a severe,
niformly fatal congenital heart defect typically character-
zed by hypoplasia of the left ventricular chamber and aorta
n association with stenosis and/or atresia of the mitral and
ortic valves (1). Since the original description of HLHS
ver 150 years ago (2), there has been extraordinary progress
n the management of this congenital heart lesion. Surgery
sually involves the 3-staged Norwood procedure, which
ltimately results in a 2-chamber heart in which the right
entricle functions as the systemic ventricle. In carefully
elected patients, the current 5-year survival now approaches
0% (3). However, the long-term outcome for these pa-
ients is unknown, and the surgical strategy can still only be
onsidered palliative.
See page 1065
Mechanistically, left-sided heart defects have been clas-
ified as so-called flow defects. Developmentally, chamber
rowth is intimately coupled to flow and/or other biophys-
cal properties of heart function, and it is therefore likely
hat the final heart form is generated at least in part, by flow
tself. It has been hypothesized that any lesion that com-
romises blood flow into or out of the developing left
entricle will cause, with graded severity, hypoplasia of the
eft-sided structures (4). Potentially, genetic mutations that
mpair normal prograde flow through the developing left
entricle could cause left-sided heart defects. As an example,
linically, there is a well-known association between the
resence of ventricular septal defects and aortic arch hypo-
lasia (5). This has led to the hypothesis that aortic arch
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the †Division of Cardiology, Department of Pediatrics, University of
alifornia, San Diego School of Medicine, San Diego, California; ‡Victor Chang(
ardiac Research Institute, Darlinghurst, Australia; and the §Faculties of Medicine
nd Science, University of New South Wales, Kensington, Australia.ypoplasia arises secondarily from decreased prograde blood
ow to the ascending aorta, due to “steal” from the left side
s a result of left-to-right shunting of blood across the
entricular septal defect. In mice, genetic and surgical
nterruption of blood flow through the outflow tract to the
ranchial arch arteries leads to abnormal branchial arch
emodeling (6). Genetically engineered mice that have a
arge ventricular septal defect also demonstrate aortic arch
ypoplasia (7), but only in some genetic backgrounds,
uggesting differential genetic sensitivity to the flow effect.
herefore, identification of genes for HLHS will likely
rovide much needed insights into the primary mechanisms
nderlying the development of left-sided structures of the
eart, including flow-responsive programs.
There has been a growing body of evidence supporting a
enetic etiology for left-sided heart defects, including HLHS.
nitially, case reports described familial recurrences of HLHS,
ith autosomal dominant, recessive, and X-linked modes of
nheritance, and variable penetrance and phenotype (4). Sub-
equent studies employing a systematic analysis by echocardi-
graphy demonstrated that there was likely to be a strong
enetic component for HLHS (8,9). Because there was a
pectrum of severity of left-sided defects occurring in affected
amily members (ranging from HLHS to bicuspid aortic valve
BAV]), it has been hypothesized that left-sided heart defects
an be due to a common genetic etiology. More recently,
tatistical analyses on families with HLHS and BAV provided
vidence implicating a predominantly genetic etiology (10,11).
There is now strong evidence implicating multiple ge-
etic loci for HLHS (4). Specifically, HLHS has been
ssociated with trisomy 13, trisomy 18, chromosome X
XO, Turner syndrome), and deletion of distal 11q (Jacob-
en syndrome) (12). Potential mutations in at least 4
enes—GJA1 (Connexin43, 6q22) (13), NKX2-5 (5q35)
14,15), NOTCH1 (9q34) (16), and HAND1 (5q33) (17)—
ave been associated with HLHS. Taken together, it is clear
hat HLHS and left-sided heart defects as a group are a
enetically heterogeneous set of disorders.
In this issue of the Journal, Hinton et al. (18) provide
urther evidence for genetic heterogeneity for HLHS. Spe-
ifically, they performed a genomewide nonparametric link-
ge analysis on 33 families with at least 1 affected member
ith HLHS. They identified 2 chromosomal loci impli-
ated in disease-causation for HLHS, with another 5 loci
eing suggestive. Four families contributed to the identifi-
ation of both loci, which is consistent with complex
nheritance of HLHS. One suggestive HLHS locus was
lso associated with BAV in a separate group of families.
lthough no obvious candidate genes were identified within
hese loci, the analysis will hopefully lead to the identifica-
ion of additional disease-causing genes for HLHS and
AV and ultimately provide important new insights into
he pathogenesis of these lesions.
At least 2 questions arise from the results of Hinton et al.18). First, why were only 2 definitive loci identified, given
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hy did HLHS and BAV share linkage with only 1
ommon locus?
As described earlier, there is convincing evidence impli-
ating as many as 8 other loci for HLHS and/or BAV, and
one of these were identified by Hinton et al. (18). The
ost obvious explanation is that the number of families
tudied was insufficient to identify more loci, even though
hey likely exist. The careful and comprehensive phenotyp-
ng that was performed by echocardiography on over 1,000
atients demonstrates the anatomic variability of HLHS.
onsequently, the anatomic subtypes could be due to the
agnitude of genetic heterogeneity and could explain why
ore loci were not identified in this relatively small family
rouping.
To answer the second question, there are at least 2
ossible explanations. First, in some cases, a single gene
utation may be sufficient to cause BAV and HLHS in the
ame family, as for the 14q23 locus identified by Hinton
t al. (18), with the specific phenotype being determined
ltimately by genetic or epigenetic modifiers, and/or envi-
onmental influences. In that case, then 1 possibility is that
ot enough families were analyzed. Second, it is noteworthy
hat BAV is very common (1% of the general population), is
risk factor for aortic valve disease, and is known to have a
omplex and heterogeneous genetic etiology. Clearly, only a
mall subset of BAVs in utero, possibly those that are the
ost restrictive, progress to HLHS. Even so, the fact that
here can be isolated aortic valve atresia with a normal left
entricle suggests that there are distinct genetic factors for
ortic valve defects and susceptibility to HLHS. Given the
eterogeneous origins of BAV unselected for functional
everity in utero, distinct loci for HLHS and BAV might be
redicted to be the predominant outcome.
mplications for therapies. One of the challenges in the
anagement of some patients with left-sided heart defects
s the decision to proceed with a 1- versus 2-ventricle repair
or patients with mild left ventricular hypoplasia. Studies
ave demonstrated that in a subset of patients with left
entricle hypoplasia, the ventricle is capable of postnatal
rowth (19). Consequently, identification of the specific
enetic cause in such patients may lead to a stratification
cheme that could facilitate the selection of patients for a 1-
ersus 2-ventricle repair.
Currently, there are no medical cures for HLHS. Al-
hough the idea of treating HLHS with drug therapies in
he future seems remote, the pioneering work by Brooke et
l. (20) on Marfan syndrome is a case in point for how the
dentification of a genetic cause of a structural heart abnor-
ality can lead to potential medical therapies that might
eplace current surgical approaches. Furthermore, some
enters are exploring fetal intervention for HLHS. Based on
he progressive nature of the defect in utero and the
ossibility of early diagnosis at fetal stages, correction of the
bstructive lesion by ultrasound-guided balloon angioplasty
ay stimulate left ventricular growth (21,22). Understand-
1ng the genetics of HLHS may aid significantly in the
ecision-making processes related to this intervention.
uture directions. The identification of new loci for
LHS is exciting. Nonetheless, the challenges that lie
head to identify specific disease-causing genes for HLHS
re immense. Identification of the HLHS disease-causing
ene(s) among 300 potential candidates identified is a
aunting task that will likely require years of further
nvestigation. Regardless, because of the rigorous studies by
inton et al. (18) and others, there is cause for hope for
mproving the outcome of this devastating congenital heart
efect.
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